Skip links
Companies
› United States › TERNS PHARMACEUTICALS, INC.
TERNS PHARMACEUTICALS, INC. logo

TERNS PHARMACEUTICALS, INC.

Active

in

Registration No.
4677159
Incorporation Date
2020-12-29
Company Type
Not disclosed
Address
FOSTER CITY, United States
Website
www.ternspharma.com/
Source: California Secretary of State — bizfile Online

TERNS PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 4677159, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 29 December 2020 and lists its registered address as FOSTER CITY, United States. 3 shareholders are on record for TERNS PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 4 October 2026.

Data Provenance
This record is sourced directly from official government registries, including California Secretary of State — bizfile Online.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

3

Three shareholders are currently on record for TERNS PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is Vanguard Group Inc, holding 7.7% — the largest recorded stake — followed by SmallCap World Fund Inc at 1.5%; the remaining 1 shareholder shown holds smaller stakes.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
Vanguard Group Inc 7.7% California Secretary of State — bizfile Online
SmallCap World Fund Inc 1.5% California Secretary of State — bizfile Online
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund 1% California Secretary of State — bizfile Online

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Chief Executive Officer of TERNS PHARMACEUTICALS, INC. currently on record is SENTHIL SUNDARAM; five officers are currently on record for TERNS PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online.

The register reports 25 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at TERNS PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

SS
SENTHIL SUNDARAM ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Executive Officer

MV
MARK VIGNOLA ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Financial Officer

SS
SENTHIL SUNDARAM ACTIVE

Residence
🇺🇸 United States
Occupation
President

SH
Scott Harris ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Development Officer

EK
Elona Kogan Esq., J.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Legal Officer

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

TERNS PHARMACEUTICALS, INC. sits 2 levels below its ultimate parent, Merck & Co., Inc., registered in United States. The full chain up to Merck & Co., Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by TERNS PHARMACEUTICALS, INC.'s own shareholder record.

Ultimate HQ
Merck & Co., Inc.
United States

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on TERNS PHARMACEUTICALS, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns TERNS PHARMACEUTICALS, INC.?

Three shareholders are currently on record for TERNS PHARMACEUTICALS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 7.7% — the largest recorded stake — followed by SmallCap World Fund Inc at 1.5%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is TERNS PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for TERNS PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does TERNS PHARMACEUTICALS, INC. have on record?

3 shareholders are shown on record for TERNS PHARMACEUTICALS, INC..

What is TERNS PHARMACEUTICALS, INC.'s company registration number?

TERNS PHARMACEUTICALS, INC.'s registration number is 4677159, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.

Is TERNS PHARMACEUTICALS, INC. still an active company?

TERNS PHARMACEUTICALS, INC.'s status on California Secretary of State — bizfile Online is listed as active.

When was TERNS PHARMACEUTICALS, INC. incorporated?

TERNS PHARMACEUTICALS, INC. was incorporated on 29 December 2020, according to California Secretary of State — bizfile Online.

What is TERNS PHARMACEUTICALS, INC.'s registered address?

The registered address on file for TERNS PHARMACEUTICALS, INC. is FOSTER CITY, United States.

Who are the officers/directors of TERNS PHARMACEUTICALS, INC.?

The Chief Executive Officer of TERNS PHARMACEUTICALS, INC. currently on record is SENTHIL SUNDARAM; five officers are currently on record for TERNS PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online. Management authority at TERNS PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does TERNS PHARMACEUTICALS, INC. have a parent company or subsidiaries?

TERNS PHARMACEUTICALS, INC. sits 2 levels below its ultimate parent, Merck & Co., Inc., registered in United States.

Can Zavia monitor changes to TERNS PHARMACEUTICALS, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to TERNS PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access TERNS PHARMACEUTICALS, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like TERNS PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 4 October 2026.

This website uses cookies to improve your web experience.